BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10225988)

  • 21. Pseudomonas aeruginosa bacteremia: resistance to antibiotics, risk factors, and patient mortality.
    Vitkauskienė A; Skrodenienė E; Dambrauskienė A; Macas A; Sakalauskas R
    Medicina (Kaunas); 2010; 46(7):490-5. PubMed ID: 20966623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical features and outcome of patients with community-acquired Pseudomonas aeruginosa bacteraemia.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Clin Microbiol Infect; 2005 May; 11(5):415-8. PubMed ID: 15819873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy.
    Kim YJ; Jun YH; Kim YR; Park KG; Park YJ; Kang JY; Kim SI
    BMC Infect Dis; 2014 Mar; 14():161. PubMed ID: 24655422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergence of multidrug resistant acinetobacter blood stream infections in febrile neutropenia patients with haematological cancers and bone marrow failure syndromes.
    Sood P; Seth T; Kapil A; Sharma V; Dayama A; Sharma S; Kumar S; Singh AK; Mishra P; Mahapatra M
    J Indian Med Assoc; 2012 Jul; 110(7):439-44. PubMed ID: 23520666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pseudomonas aeruginosa bacteremia: an analysis of 123 episodes, with particular emphasis on the effect of antibiotic therapy.
    Siegman-Igra Y; Ravona R; Primerman H; Giladi M
    Int J Infect Dis; 1998; 2(4):211-5. PubMed ID: 9763504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Staphylococcus aureus bacteremia in patients with hematologic malignancies: a retrospective case-control study.
    Venditti M; Falcone M; Micozzi A; Carfagna P; Taglietti F; Serra PF; Martino P
    Haematologica; 2003 Aug; 88(8):923-30. PubMed ID: 12935981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Pseudomonas aeruginosa bacteraemia in a tertiary hospital: Mortality and prognostic factors.
    Callejas-Díaz A; Fernández-Pérez C; Ramos-Martínez A; Múñez-Rubio E; Sánchez-Romero I; Vargas Núñez JA
    Med Clin (Barc); 2019 Feb; 152(3):83-89. PubMed ID: 29885868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies.
    Chong Y; Yakushiji H; Ito Y; Kamimura T
    Int J Infect Dis; 2011 Apr; 15(4):e277-81. PubMed ID: 21324723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pseudomonas aeruginosa bacteraemia in patients with hematologic malignancies: risk factors, treatment and outcome.
    Tofas P; Samarkos M; Piperaki ET; Kosmidis C; Triantafyllopoulou ID; Kotsopoulou M; Pantazatou A; Perlorentzou S; Poulli A; Vagia M; Daikos GL
    Diagn Microbiol Infect Dis; 2017 Aug; 88(4):335-341. PubMed ID: 28529091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical predictors of Pseudomonas aeruginosa bacteremia among Gram-negative bacterial infections in non-neutropenic patients with solid tumor.
    Joo EJ; Kang CI; Ha YE; Kim J; Kang SJ; Park SY; Lee NY; Wi YM; Chung DR; Peck KR; Song JH
    J Infect; 2011 Sep; 63(3):207-14. PubMed ID: 21777616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems.
    Lee CH; Su TY; Ye JJ; Hsu PC; Kuo AJ; Chia JH; Lee MH
    J Microbiol Immunol Infect; 2017 Oct; 50(5):677-683. PubMed ID: 26188977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
    El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
    Yoshida M; Karasawa M; Naruse T; Fukuda M; Hirashima K; Oh H; Ninomiya H; Abe T; Saito K; Shishido H; Moriyama Y; Shibata A; Motoyoshi K; Nagata N; Miura Y
    Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between mortality and microbiological parameters in febrile neutropenic patients with hematological malignancies.
    Calik S; Ari A; Bilgir O; Cetintepe T; Yis R; Sonmez U; Tosun S
    Saudi Med J; 2018 Sep; 39(9):878-885. PubMed ID: 30251730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies.
    Kara Ö; Zarakolu P; Aşçioğlu S; Etgül S; Uz B; Büyükaşik Y; Akova M
    Infect Dis (Lond); 2015; 47(10):686-93. PubMed ID: 26024284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased risk of death with recurrent Pseudomonas aeruginosa bacteremia.
    McCarthy KL; Paterson DL
    Diagn Microbiol Infect Dis; 2017 Jun; 88(2):152-157. PubMed ID: 28366610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
    Chee L; Brown M; Sasadeusz J; MacGregor L; Grigg AP
    J Infect; 2008 Apr; 56(4):227-33. PubMed ID: 18342947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors and outcome of Pseudomonas aeruginosa bacteremia among adults visiting the ED.
    Lee CC; Lee CH; Hong MY
    Am J Emerg Med; 2012 Jul; 30(6):852-60. PubMed ID: 21855263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias.
    Micozzi A; Gentile G; Minotti C; Cartoni C; Capria S; Ballarò D; Santilli S; Pacetti E; Grammatico S; Bucaneve G; Foà R
    BMC Infect Dis; 2017 Mar; 17(1):203. PubMed ID: 28283020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of nosocomial bloodstream infections in adult neutropenic patients: a prospective cohort and matched case-control study.
    Wisplinghoff H; Cornely OA; Moser S; Bethe U; Stützer H; Salzberger B; Fätkenheuer G; Seifert H
    Infect Control Hosp Epidemiol; 2003 Dec; 24(12):905-11. PubMed ID: 14700405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.